Dynatrace Holdings LLC shares climbed to a 52-week high of $54.93, trading just below that peak at $54.95, extending a 39% surge over the past six months. The stock has gained 13.84% over the past year, boosting the company’s market valuation to $15.82 billion.
Multiple analysts raised their price targets following the milestone. Morgan Stanley upgraded Dynatrace from Equalweight to Overweight, increasing its price target from $58 to $65. UBS maintained a Buy rating with a $65 target, pointing to a strong growth outlook for fiscal year 2027 and first-quarter organic net new annual recurring revenue (ARR) growth of 41%. DA Davidson also reiterated a Buy with a $65 target. Canaccord Genuity lifted its price target from $46 to $60, highlighting a $275 million share repurchase in the most recent quarter as part of the company’s capital return program.
Dynatrace reported 41% year-over-year growth in first-quarter organic net new ARR, according to UBS. Morgan Stanley projects that net-new ARR growth will exceed 20% by fiscal year 2027. In July, the company announced the acquisition of Arize, an agent observability provider, for $915 million.
